Mineralocorticoid receptor blockade reduced oxidative stress in renal transplant recipients: A double-blind, randomized pilot study

American Journal of Nephrology

Volumn 37, Issue 5, 2013, Pages 481-490

  Ojeda Cervantes, Marcos ^a   Barrera Chimal, Jonatan ^a,b   Alberú, Josefina ^a   Pérez Villalva, Rosalba ^a,b   Morales Buenrostro, Luis Eduardo ^a   Bobadilla, Norma A ^a,b  

^a INSTITUTO NACIONAL DE CIENCIAS MÉDICAS Y NUTRICIÓN SALVADOR ZUBIRÁN   (Mexico)

^b UNIVERSIDAD NACIONAL AUTÓNOMA DE MÉXICO   (Mexico)

Author keywords

Acute kidney injury; Aldosterone; Oxidative stress; Slow graft function; Urinary biomarkers level

Indexed keywords

BASILIXIMAB; CREATININE; DACLIZUMAB; HEAT SHOCK PROTEIN 72; HYDROGEN PEROXIDE; INTERLEUKIN 18; KIDNEY INJURY MOLECULE 1; MINERALOCORTICOID RECEPTOR; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; PLACEBO; POTASSIUM; PREDNISONE; REACTIVE OXYGEN METABOLITE; SPIRONOLACTONE; TACROLIMUS; BIOLOGICAL MARKER;

ACUTE GRAFT REJECTION; ACUTE KIDNEY TUBULE NECROSIS; ADULT; AGE; ARTICLE; CLINICAL ARTICLE; COLD ISCHEMIA; COMPLEMENT DEPENDENT CYTOTOXICITY; CONTROLLED STUDY; CONVERSION TO OPEN SURGERY; CREATININE BLOOD LEVEL; DELAYED GRAFT FUNCTION; DOUBLE BLIND PROCEDURE; FEMALE; FIBROSING ALVEOLITIS; FOLLOW UP; GENDER; GRAFT RECIPIENT; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; HYPERKALEMIA; IMMUNOSUPPRESSIVE TREATMENT; KIDNEY BIOPSY; KIDNEY FUNCTION; KIDNEY GRAFT; KIDNEY GRAFT REJECTION; KIDNEY TRANSPLANTATION; LIVING DONOR; MALE; NEPHRECTOMY; OXIDATIVE STRESS; PILOT STUDY; POTASSIUM BLOOD LEVEL; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; RECEPTOR BLOCKING; RENAL GRAFT DYSFUNCTION; RENAL REPLACEMENT THERAPY; URINALYSIS; URINE VOLUME; ISCHEMIA; KIDNEY TUBULE DAMAGE; OUTCOME ASSESSMENT; TREATMENT INDICATION;

ACUTE KIDNEY INJURY; ADULT; BIOLOGICAL MARKERS; DOUBLE-BLIND METHOD; FEMALE; HUMANS; KIDNEY FUNCTION TESTS; KIDNEY TRANSPLANTATION; LIVING DONORS; MALE; MINERALOCORTICOID RECEPTOR ANTAGONISTS; OXIDATIVE STRESS; PILOT PROJECTS; POTASSIUM; SPIRONOLACTONE; YOUNG ADULT;

EID: 84876798791     PISSN: 02508095     EISSN: 14219670     Source Type: Journal    
DOI: 10.1159/000350539     Document Type: Article

References (59)

1. Perico N, Cattaneo D, Sayegh MH, Remuzzi G: Delayed graft function in kidney transplantation. Lancet 2004; 364: 1814-1827
2. Yarlagadda SG, Coca SG, Formica RN Jr, Poggio ED, Parikh CR: Association between delayed graft function and allograft and patient survival: A systematic review and metaanalysis. Nephrol Dial Transplant 2009; 24: 1039-1047
3. Tilney NL, Guttmann RD: Effects of initial ischemia/reperfusion injury on the transplanted kidney. Transplantation 1997; 64: 945-947
4. Goes N, Urmson J, Ramassar V, Halloran PF: Ischemic acute tubular necrosis induces an extensive local cytokine response. Evidence for induction of interferon-γ, transforming growth factor-β 1, granulocyte-macrophage colony- stimulating factor, interleukin-2, and interleukin- 10. Transplantation 1995; 59: 565- 572
5. Schwarz C, Regele H, Steininger R, Hansmann C, Mayer G, Oberbauer R: The contribution of adhesion molecule expression in donor kidney biopsies to early allograft dysfunction. Transplantation 2001; 71: 1666-1670
6. Koo DD, Welsh KI, Roake JA, Morris PJ, Fuggle SV: Ischemia/reperfusion injury in human kidney transplantation: An immunohistochemical analysis of changes after reperfusion. Am J Pathol 1998; 153: 557-566
7. Saikumar P, Dong Z, Weinberg JM, Venkatachalam MA: Mechanisms of cell death in hypoxia/reoxygenation injury. Oncogene 1998; 17: 3341-3349
8. Kourembanas S, Marsden PA, McQuillan LP, Faller DV: Hypoxia induces endothelin gene expression and secretion in cultured human endothelium. J Clin Invest 1991; 88: 1054- 1057
9. Bachmann S, Mundel P: Nitric oxide in the kidney: Synthesis, localization, and function. Am J Kidney Dis 1994; 24: 112-129
10. Pitt B, Zannad F, Remme WJ, et al: The effect of spironolactone on morbidity and mortality in patients with severe heart failure. Randomized Aldactone Evaluation Study Investigators. N Engl J Med 1999; 341: 709-717
11. Rocha R, Stier CT Jr, Kifor I, et al: Aldosterone: A mediator of myocardial necrosis and renal arteriopathy. Endocrinology 2000; 141: 3871-3878
12. Pitt B, Remme W, Zannad F, et al: Eplerenone, a selective aldosterone blocker, in patients with left ventricular dysfunction after myocardial infarction. N Engl J Med 2003; 348: 1309-1321
13. Chrysostomou A, Pedagogos E, MacGregor L, Becker GJ: Double-blind, placebo-controlled study on the effect of the aldosterone receptor antagonist spironolactone in patients who have persistent proteinuria and are on long-term angiotensin-converting enzyme inhibitor therapy, with or without an angiotensin II receptor blocker. Clin J Am Soc Nephrol 2006; 1: 256-262
14. Chrysostomou A, Becker G: Spironolactone in addition to ACE inhibition to reduce proteinuria in patients with chronic renal disease. N Engl J Med 2001; 345: 925-926
15. Hostetter TH, Ibrahim HN: Aldosterone in chronic kidney and cardiac disease. J Am Soc Nephrol 2003; 14: 2395-2401
16. Joffe HV, Adler GK: Effect of aldosterone and mineralocorticoid receptor blockade on vascular inflammation. Heart Fail Rev 2005; 10: 31-37
17. Rocha R, Chander PN, Khanna K, Zuckerman A, Stier CT Jr: Mineralocorticoid blockade reduces vascular injury in stroke-prone hypertensive rats. Hypertension 1998; 31: 451-458
18. Greene EL, Kren S, Hostetter TH: Role of aldosterone in the remnant kidney model in the rat. J Clin Invest 1996; 98: 1063-1068
19. Schiffrin EL: Effects of aldosterone on the vasculature. Hypertension 2006; 47: 312-318
20. Nguyen Dinh CA, Griol-Charhbili V, Loufrani L, et al: The endothelial mineralocorticoid receptor regulates vasoconstrictor tone and blood pressure. FASEB J 2010; 24: 2454-2463
21. Griol-Charhbili V, Fassot C, Messaoudi S, Perret C, Agrapart V, Jaisser F: Epidermal growth factor receptor mediates the vascular dysfunction but not the remodeling induced by aldosterone/salt. Hypertension 2011; 57: 238-244
22. Arima S, Kohagura K, Xu HL, et al: Nongenomic vascular action of aldosterone in the glomerular microcirculation. J Am Soc Nephrol 2003; 14: 2255-2263
23. Gros R, Ding Q, Armstrong S, O'Neil C, Pickering JG, Feldman RD: Rapid effects of aldosterone on clonal human vascular smooth muscle cells. Am J Physiol Cell Physiol 2007; 292:C788-C794
24. Leopold JA, Dam A, Maron BA, et al: Aldosterone impairs vascular reactivity by decreasing glucose-6-phosphate dehydrogenase activity. Nat Med 2007; 13: 189-197
25. Feria I, Pichardo I, Juarez P, et al: Therapeutic benefit of spironolactone in experimental chronic cyclosporine A nephrotoxicity. Kidney Int 2003; 63: 43-52
26. Perez-Rojas JM, Derive S, Blanco JA, et al: Renocortical mRNA expression of vasoactive factors during spironolactone protective effect in chronic cyclosporine nephrotoxicity. Am J Physiol Renal Physiol 2005; 289:F1020- F1030
27. Perez-Rojas J, Blanco JA, Cruz C, et al: Mineralocorticoid receptor blockade confers renoprotection in preexisting chronic cyclosporine nephrotoxicity. Am J Physiol Renal Physiol 2007; 292:F131-F139
28. Mejia-Vilet JM, Ramirez V, Cruz C, Uribe N, Gamba G, Bobadilla NA: Renal ischemia-reperfusion injury is prevented by the mineralocorticoid receptor blocker spironolactone. Am J Physiol Renal Physiol 2007; 293:F78- F86
29. Sanchez-Pozos K, Barrera-Chimal J, Garzon- Muvdi J, et al: Recovery from ischemic acute kidney injury by spironolactone administration. Nephrol Dial Transplant 2012; 27: 3160- 3169
30. Ramirez V, Trujillo J, Valdes R, et al: Adrenalectomy prevents renal ischemia-reperfusion injury. Am J Physiol Renal Physiol 2009; 297:F932-F942
31. Barrera-Chimal J, Perez-Villalva R, Cortes- Gonzalez C, et al: Hsp72 is an early and sensitive biomarker to detect acute kidney injury. EMBO Mol Med 2011; 3: 5-20
32. Ramirez V, Mejia-Vilet JM, Hernandez D, Gamba G, Bobadilla NA: Radicicol, a heatshock protein 90 inhibitor, reduces glomerular filtration rate. Am J Physiol Renal Physiol 2008; 295:F1044-F1051
33. Simmons MN, Schreiber MJ, Gill IS: Surgical renal ischemia: A contemporary overview. J Urol 2008; 180: 19-30
34. Mehrotra A, Rose C, Pannu N, Gill J, Tonelli M, Gill JS: Incidence and consequences of acute kidney injury in kidney transplant r ecipients. Am J Kidney Dis 2012; 59: 558- 565
35. Loutfi I, Batchelor JR, Lavender JP: Imaging and quantitation of renal transplant rejection in the rat by in vivo use of 111 In-labelled antilymphocyte and anti-class I and II major histocompatibility complex monoclonal antibodies. Transplant Proc 1991; 23: 2143-2146
36. Azuma H, Nadeau K, Takada M, Mackenzie HS, Tilney NL: Cellular and molecular predictors of chronic renal dysfunction after initial ischemia/reperfusion injury of a single kidney. Transplantation 1997; 64: 190-197
37. Green CJ, Gower JD, Healing G, Cotterill LA, Fuller BJ, Simpkin S: The importance of iron, calcium and free radicals in reperfusion injury: An overview of studies in ischaemic rabbit kidneys. Free Radic Res Commun 1989; 7: 255-264
38. Conger JD, Robinette JB, Hammond WS: Differences in vascular reactivity in models of ischemic acute renal failure. Kidney Int 1991; 39: 1087-1097
39. Donnahoo KK, Meng X, Ayala A, Cain MP, Harken AH: Meldrum DR. Early kidney TNF-α expression mediates neutrophil infiltration and injury after renal ischemiareperfusion. Am J Physiol 1999; 277:R922- R929
40. Donnahoo KK, Meldrum DR, Shenkar R, Chung CS, Abraham E, Harken AH: Early renal ischemia, with or without reperfusion, activates NF-κB and increases TNF-α bioactivity in the kidney. J Urol 2000; 163: 1328- 1332
41. Lopez-Hernandez FJ, Lopez-Novoa JM: Role of TGF-β in chronic kidney disease: An integration of tubular, glomerular and vascular effects. Cell Tissue Res 2012; 347: 141-154
42. Stroo I, Stokman G, Teske GJ, et al: Chemokine expression in renal ischemia/reperfusion injury is most profound during the reparative phase. Int Immunol 2010; 22: 433-442
43. Basile DP, Leonard EC, Beal AG, Schleuter D, Friedrich JL: Persistent oxidative stress following renal ischemia reperfusion injury increases Ang II hemodynamic and fibrotic activity. Am J Physiol Renal Physiol 2012; 302:F1494-F1502
44. Schneider MP, Sullivan JC, Wach PF, et al: Protective role of extracellular superoxide dismutase in renal ischemia/reperfusion injury. Kidney Int 2010; 78: 374-381
45. Xie J, Guo Q: Apoptosis antagonizing transcription factor protects renal tubule cells against oxidative damage and apoptosis induced by ischemia-reperfusion. J Am Soc Nephrol 2006; 17: 3336-3346
46. Li C, Jackson RM: Reactive species mechanisms of cellular hypoxia-reoxygenation injury. Am J Physiol Cell Physiol 2002; 282:C227-C241
47. Basile DP, Friedrich JL, Spahic J, et al: Impaired endothelial proliferation and mesenchymal transition contribute to vascular rarefaction following acute kidney injury. Am J Physiol Renal Physiol 2011; 300:F721- F733
48. Basile DP, Donohoe D, Roethe K, Osborn JL: Renal ischemic injury results in permanent damage to peritubular capillaries and influences long-term function. Am J Physiol Renal Physiol 2001; 281:F887-F899
49. Yang L, Besschetnova TY, Brooks CR, Shah JV, Bonventre JV: Epithelial cell cycle arrest in G2/M mediates kidney fibrosis after injury. Nat Med 2010; 16: 535-543
50. Bechtel W, McGoohan S, Zeisberg EM, et al: Methylation determines fibroblast activation and fibrogenesis in the kidney. Nat Med 2010; 16: 544-550
51. Macunluoglu B, Arikan H, Atakan A, et al: Effects of spironolactone in an experimental model of chronic cyclosporine nephrotoxicity. Transplant Proc 2008; 40: 273-278
52. Thomson AW, McAuley FT, Whiting PH, Simpson JG: Angiotensin-converting enzyme inhibition or aldosterone antagonism reduces cyclosporine nephrotoxicity in the rat. Transplant Proc 1987; 19: 1242-1243
53. Bobadilla NA, Gamba G: New insights into the pathophysiology of cyclosporine nephrotoxicity: A role of aldosterone. Am J Physiol Renal Physiol 2007; 293:F2-F9
54. Zhao M, Celerier I, Bousquet E, et al: Mineralocorticoid receptor is involved in rat and human ocular chorioretinopathy. J Clin Invest 2012; 122: 2672-2679
55. Qin W, Rudolph AE, Bond BR, et al: Transgenic model of aldosterone-driven cardiac hypertrophy and heart failure. Circ Res 2003; 93: 69-76
56. Nishiyama A, Yao L, Nagai Y, et al: Possible contributions of reactive oxygen species and mitogen-activated protein kinase to renal injury in aldosterone/salt-induced hypertensive rats. Hypertension 2004; 43: 841-848
57. Hayashi H, Kobara M, Abe M, et al: Aldosterone nongenomically produces NADPH oxidase- dependent reactive oxygen species and induces myocyte apoptosis. Hypertens Res 2008; 31: 363-375
58. Zhu X, Manning RD Jr, Lu D, et al: Aldosterone stimulates superoxide production in macula densa cells. Am J Physiol Renal Physiol 2011; 301:F529-F535
59. Iwashima F, Yoshimoto T, Minami I, Sakurada M, Hirono Y, Hirata Y: Aldosterone induces superoxide generation via Rac1 activation in endothelial cells. Endocrinology 2008; 149: 1009-1014